About 10–35% of ALM are BRAF mutated, ∼15–30% are NRAS mutated at exons 2 and 3, ∼11–23% are NF1 mutated, ∼45–58% carry mutations in TWT. Here, BRAF is linked to acral lentiginous melanoma.